Document is current
Any future updates will be listed below
-
Authors
Altab, Gulam
Merry, Brian J.
Beckett, Charles W.
Raina, Priyanka
Lopes, Inês
Goljanek-Whysall, Katarzyna
de Magalhães, João Pedro
-
Funding
Funding for this research was provided by:
Medical Research Council (MR/R502182/1)
- License Information
-
More Information
Article History
Received: 13 May 2024
Accepted: 14 November 2024
First Online: 13 January 2025
Declarations
:
: The animal study from which samples were collected [] received ethical approval from the University of Liverpool’s Animal Welfare Committee and adhered to the Animal (Scientific Procedures) Act 1986 and its amendments. The research proposal underwent an ethical review and scoring process before grant submission, followed by additional review from the funding body. After funding approval, a Project Licence (PPL 40/2533), classified as "Mild," was obtained from the Home Office Animal Inspectorate, which involved detailed scrutiny and compliance with the principles of Replace, Reduce, and Refine. The Home Office conducted unannounced visits to ensure adherence to protocols, and animals were humanely euthanised by cervical dislocation after stunning, as required by law. The process was overseen by licensed officials to maintain high standards of animal welfare and ethical compliance.
: Not applicable.
: JPM is CSO of YouthBio Therapeutics, an advisor/consultant for the BOLD Longevity Growth Fund, 199 Biotechnologies, and NOVOS, and the founder of Magellan Science Ltd, a company providing consulting services in longevity science. There are no competing interests declared by any other authors.There are no competing interests declared by any other authors.
